| Drug Name |
Dinoprostone |
| Drug ID |
BADD_D00684 |
| Description |
Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour. |
| Indications and Usage |
For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. Also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). Other indications include improving the cervical inducibility (cervical "ripening") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpartum hemorrhage. |
| Marketing Status |
approved |
| ATC Code |
G02AD02 |
| DrugBank ID |
DB00917
|
| KEGG ID |
D00079
|
| MeSH ID |
D015232
|
| PubChem ID |
5280360
|
| TTD Drug ID |
D06FEA
|
| NDC Product Code |
0009-0058; 55566-2800; 82231-104; 68245-0015; 40016-012; 12079-0485; 45542-1153; 0009-3359 |
| UNII |
K7Q1JQR04M
|
| Synonyms |
Dinoprostone | PGE2 alpha | alpha, PGE2 | Prostaglandin E2alpha | E2alpha, Prostaglandin | Prostaglandin E2 | E2, Prostaglandin | Prostaglandin E2 alpha | E2 alpha, Prostaglandin | alpha, Prostaglandin E2 | PGE2 | PGE2alpha | Prepidil Gel | Gel, Prepidil | Prostenon |
